Clinical trials are crucial for medical advancement, as they help determine whether a new treatment, device, or procedure works and is safe for the general population. However, people of color are often underrepresented in many drug trials. “For decades, drugs have been largely tested on white, non-Hispanic men,” says Geeta Yadav, MD, a board-certified dermatologist and founder of FACET Dermatology. “There’s evidence that women and patients of color respond quite differently to medication. Failure to test drugs on a diverse patient population can lead to many issues, including a lack of accessibility to effective medical intervention, compounded health disparities between patient populations,…
